Linked In
News In
Linked In

You are viewing your 1 complimentary article.

Register now to receive full access.

Already registered?

Login | Join us now

Monsanto rejects $62bn Bayer offer - but says open to talks

Twitter Linkedin eCard

Shares in Monsanto gained, even as the seeds giant rejected a $62bn bid from Germany's Bayer as "financially inadequate", as the US group said that was open, nonetheless, to "constructive" talks on a deal.

Hugh Grant, the Monsanto chairman and chief executive, said that Bayer's $122-a-share offer, which was unveiled on Monday, "significantly undervalues our company".

The deal, which offers a premium of 37% to Monsanto shareholders, also falls short in details on financing, which Bayer has said it will raise through debt and a rights issue, and on winning approval from antitrust regulators, Mr Grant said.

The offer "does not adequately address or provide reassurance for some of the potential financing and regulatory risks related to the acquisition", he said.

'Constructive conversations'

However, Monsanto added that it was "open to continued and constructive conversations" over whether a deal in the best interests of its shareholders could be sealed.

"We believe in the substantial benefits an integrated strategy could provide to growers and broader society, and have long respected Bayer's business," Mr Grant said.

Monsanto shares stood 2.7% higher at $108.86 in late deals in New York.

'Prepared to proceed immediately'

In fact, Bayer, which is in agriculture strong in agrichemicals rather than seeds, would appear one of the best bets, on antitrust grounds, for a tie-up with Monsanto, which has a relatively small presence in sprays, so limiting the threat of a deal raising substantial monopoly concerns.

Monsanto has long espoused the benefits to mergers in the sector, given the growing costs of research and the more difficult market climate prompted by low crop prices, and indeed last year failed in an effort to buy Swiss rival Syngenta.

Bayer on Monday said it was "prepared to proceed immediately with due diligence and negotiations and to achieve an agreed transaction" with Monsanto.

The German group also said it was "highly confident in its ability to finance the transaction based on advanced discussions with and support from its financing banks".

And on antitrust, Bayer said it had "a successful track record of working with global authorities to secure the necessary regulatory approvals".

By Mike Verdin

Twitter Linkedin eCard
Related Stories

Will protein prices fight back against fat in dairy markets?

Prices of fats remain elevated against protein values in dairy - at a time when the opposite is true in markets for oilseed products

World phosphate, potash shipments to grow in 2018, helped by Chinese needs

Mosaic forecasts further demand expansion, as it heralds a "transformational year" for its own fortunes, after a 2017 marred by a one-time tax charge

Deere lifts sales hopes - even as it unveils biggest loss in 25 years

The maker of John Deere tractors flags "strengthening" market conditions, but swallows a huge writedown prompted by US tax retorms

Plant Impact agrees takeover by Croda, after failure of Bayer contract

The crop enhancement group, floored by the failure of a supply deal with Bayer, agrees a takeover by a maker of chemicals from anti-wrinkle creams to floor coatings
Home | About | RSS | Commodities | Companies | Markets | Legal disclaimer | Privacy policy | Contact

Our Brands: Comtell | Feedinfo | FGInsight

© 2017 and Agrimoney are trademarks of Agrimoney Ltd
Agrimoney is part of AgriBriefing Ltd
Agrimoney Ltd is registered in England & Wales. Registered number: 09239069